[Ip-health] CSIS event on IP and licensing - Sept 26

Steven Knievel sknievel at citizen.org
Tue Sep 12 08:00:09 PDT 2017


http://mailchi.mp/csis.org/invitation-innovation-and-access-the-role-of-ip-licensing?e=d4a98690bf 


Innovation and Access: the Role of IP Licensing
 

 
Keynote speaker

Quentin Palfrey
Co-Director, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University

 
Followed by a panel discussion featuring

Dr. Robert Bertram
Chief Scientist, Bureau for Food Security, United States Agency for International Development

Dr. Carol Mimura
Assistant Vice Chancellor, Office of Intellectual Property & Research Alliances, University of California, Berkeley

Gregg Alton
Executive Vice President, Corporate and Medical Affairs, Gilead Sciences, Inc.

 

Moderated by

Scott Miller
Senior Adviser and Scholl Chair in International Business, CSIS

 
Register
https://www.csis.org/node/42721
 
Tuesday, September 26, 2017
10:00 am - 12:00 pm
 
CENTER FOR STRATEGIC & INTERNATIONAL STUDIES
1616 RHODE ISLAND AVE NW, WASHINGTON, D.C. 20036

 
1st Floor
 
Please join the CSIS Scholl Chair in International Business for a morning conference on humanitarian licensing. This exciting new concept in IP regulation that seeks to improve access to new innovation in humanitarian contexts while also protecting the rights of IP owners and fostering innovation.

Sponsors:

Gilead
Berkman Klein Center
Berkeley IPIRA

Steven Knievel
Access to Medicines Advocate
Public Citizen | Protecting Health, Safety and Democracy
TEL: +1 202-588-7769
1600 20th St. NW, Washington, DC 20009
URL: http://www.citizen.org/access  
Twitter: @PCMedsAccess

Public Citizen Foundation participates in the Combined Federal Campaign with the CFC Code 11168.





More information about the Ip-health mailing list